expand_moreexpand_less
Aeon
Al Jazeera
América Economía
Blitz
Buenos Aires Herald
Deutsche Welle
Dnevnik
E-International
Haaretz
Il Manifesto Global
Japan Today
Khaama PressMiddle East Monitor
New Eastern OutlookNikkei Asian ReviewOped Column
Pravda.sk
Project Syndicate
Psychology TodayRT.comSME.sk
South China Morning PostThe Asahi ShimbunThe Japan NewsThe Japan Times
The Korea TimesThe Times of IsraelThe Times of Israel (Blogs)
TRT WorldVečer
العين الإخبارية 
Toi StaffAgenciesJacob MagidEmanuel FabianLuke TressRossella TercatinLazar BermanJeremy SharonNurit YohananThe Japan News EditorialReutersSharon WrobelSam Sokol
Tarik Cyril AmarAhmed NajarBart SchutElizabeth SchumacherAmérica EconomíaJessica SteinbergGrace GilsonCharlie SummersSam Goldstein Ph.dZev StubRicardo MartinsNoam Lehmann
Jeffrey Bernstein Ph.dDiana BletterNina KnavsNik MartinRosie BirchardArthur SullivanDavid HorovitzCathrin SchaerSanja Kljajic
Gideon LevyHassan Abo Qamar
Maryam AldossariEmina HodžićSue SurkesAmanda Borschel-Dan
Sabine Kinkartz
Jennifer Gerlach Lcsw
Andrew Mitrovica
Tafi Mhaka
Belen FernandezHadeel AwadBen SalesSebastjan MorozovNava FreibergMatthew Ward Agius
|
 |
Ashleigh FurlongPolitico |
AstraZeneca will pay $425 million upfront for EsoBiotec and may spend up to $575 million more in development and regulatory milestones, the companies...
Earnings per share excluding some items reached €2.86 ($3.10) in the third quarter, exceeding analysts’ estimates.
Drugs containing finasteride and dutasteride when taken by mouth have a “known risk of psychiatric side effects, including depression,” the...
login
who are we?
contact us
qosheapp
